SIP sigma pharmaceuticals limited

what next?, page-6

  1. 76 Posts.
    not a good look. No CEO. No CFO.

    There may be a good reason to get rid of both of those people, however, I would think there would be limited reason of getting rid of both at the same time and with no replacement.

    I watch Orbis and Lazard with interest, but they don't get it right everytime. If they did, you would see returns from their funds smashing the daylights over the ASX benchmark.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.